Gastrointestinal adverse effects of GLP-1/GIP agonist therapy, including nausea, vomiting, and constipation, are common
It is not approved by the FDA for fat loss or any other use, and any clinical application falls under the supervision of a licensed medical provider
This matters for tissue strength, healing capacity, and overall resilience, especially as hormonal changes during perimenopause affect collagen production
If hair loss is severe, ongoing, or continues after weight loss has slowed, speak to a doctor to rule out other causes such as nutritional deficiencies, thyroid conditions, or unrelated hair disorders
The Cellular Continuum : The surge of cAMP is not uniform
Cat# 423105) and incubated for 15 to 30 min at room temperature